FDA — authorised 21 March 1963
- Application: NDA014173
- Marketing authorisation holder: WYETH AYERST
- Local brand name: PROKETAZINE
- Indication: CONCENTRATE — ORAL
- Status: approved
🇺🇸 CARPHENAZINE MALEATE in United States
FDA authorised CARPHENAZINE MALEATE on 21 March 1963
Marketing authorisations
FDA
- Status: approved
FDA
- Application: NDA012768
- Marketing authorisation holder: WYETH AYERST
- Local brand name: PROKETAZINE
- Indication: TABLET — ORAL
- Status: approved
CARPHENAZINE MALEATE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is CARPHENAZINE MALEATE approved in United States?
Yes. FDA authorised it on 21 March 1963; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for CARPHENAZINE MALEATE in United States?
WYETH AYERST holds the US marketing authorisation.